Oppenheimer Asset Management Inc. Has $222,000 Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Oppenheimer Asset Management Inc. lifted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 5.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,222 shares of the company’s stock after acquiring an additional 1,601 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.08% of Viemed Healthcare worth $222,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Evernest Financial Advisors LLC acquired a new stake in shares of Viemed Healthcare during the second quarter valued at about $66,000. Perkins Coie Trust Co acquired a new stake in Viemed Healthcare during the 3rd quarter worth approximately $73,000. Victory Capital Management Inc. grew its holdings in Viemed Healthcare by 21.1% during the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after acquiring an additional 2,226 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of Viemed Healthcare during the third quarter valued at $89,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in shares of Viemed Healthcare in the first quarter worth approximately $97,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Trading Down 0.8 %

NASDAQ VMD opened at $8.54 on Thursday. The business has a 50 day simple moving average of $8.42 and a 200 day simple moving average of $7.54. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $10.44. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The stock has a market capitalization of $332.55 million, a P/E ratio of 31.63 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $58.00 million during the quarter.

Insiders Place Their Bets

In other Viemed Healthcare news, Director Nitin Kaushal sold 30,000 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the transaction, the director now directly owns 126,843 shares in the company, valued at approximately $1,212,619.08. This trade represents a 19.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the completion of the sale, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.